ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGTX Sigilon Therapeutics Inc

22.47
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 21.80
Ask Price 23.01
News -
Day High

Low
3.80

52 Week Range

High
28.00

Day Low
Share Name Share Symbol Market Stock Type
Sigilon Therapeutics Inc SGTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 22.47 19:00:00
Open Price Low Price High Price Close Price Previous Close
22.47 22.47
Trades Shares Traded Average Volume 52 Week Range
0 0 - 3.80 - 28.00
Last Trade Type Quantity Price Currency
- 0 US$ 22.47 USD

Sigilon Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 56.50M - - - -2.55
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sigilon Therapeutics News

Date Time Source News Article
8/21/202307:22Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section..
8/15/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
8/14/202306:25PR Newswire (US)Lilly Completes Acquisition of Sigilon Therapeutics
8/11/202315:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in..
8/11/202315:20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration..
8/11/202315:16Edgar (US Regulatory)Form 8-K - Current report
8/11/202315:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
8/11/202315:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
8/11/202315:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
8/10/202307:31Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements:..
8/07/202307:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/202315:06Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements:..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SGTX Message Board. Create One! See More Posts on SGTX Message Board See More Message Board Posts

Historical SGTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year9.722728.003.8018.88116,05012.75131.11%
3 Years198.25217.233.7742.12152,337-175.78-88.67%
5 Years308.75706.11713.7790.24151,139-286.28-92.72%

Sigilon Therapeutics Description

Sigilon Therapeutics Inc is a clinical stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients.

Your Recent History

Delayed Upgrade Clock